Technology Networks

HIV Researchers Solve Key Puzzle After 20 Years of Trying
Researchers have grown a crystal that reveals the structure of an enzyme integrase, which is found in retroviruses like HIV.

Langton Howarth and Select Biosciences partner to offer tailored life science recruitment services
Leading Life Science Recruitment firm Langton Howarth has today announced that they are to partner with Select Biosciences, the premier Biomedical Science Conference Production Company.

Linden Acquires Hycor Biomedical Business from Agilent Technologies
Acquisition strengthens Linden’s position to compete in the high-growth segments of in vitro diagnostics global allergy, autoimmune and urinalysis.

NIH Scientists Identify Maternal and Fetal Genes that Increase Preterm Birth Risk
Findings support view of preterm labor as immune response to infection or injury.

Novozymes and Prometic Enter Into Alliance for Purification of Albumin-Fusion Proteins
Both the companies will jointly promote the use of a new synthetic-ligand affinity adsorbent, AlbuPure®.

Vertex Announces Results from Phase 2a Trial of VX-809
Data support planned combination trial of VX-809 and VX-770 in second half of 2010 for CF patients with the F508del mutation.

PITTCON Conference & Exposition 2010, Orlando, Florida
28 February 2010 - 05 March 2010

Pittcon 2010, the world’s largest annual conference and exposition for laboratory science. Pittcon offers the latest innovations from nearly 1,000 exhibitors, unique networking opportunities with world renowned scientists and exceptional educational opportunities.

CNPN Symposium - Montreal, Canada
09 May 2010 - 10 May 2010

CNPN Symposium provides an open forum for scientists to present and discuss new developments in proteomic research. Features include a world-class program of invited speakers from industry and academia, poster presentations and exhibitor showcases.

Advances in Antibody and Peptide Therapeutics, 8-9 June 2010, Berlin, Germany
08 June 2010 - 09 June 2010

This conference will be following on from the successful Peptides Europe conferences. It will cover topics looking into the utilisation of peptides and antibodies in therapies for an array of diseases, which, in terms of patient treatment, promises to be huge in the future. Our conference will give delegates the latest on the techniques being used.

Postdoctoral Research Associate
Northeastern University
The Center for Drug Discovery at Northeastern University is dedicated to designing and discovering novel medications, developing technologies, and training scientists in the multidisciplinary field of drug discovery. We are recruiting a Postdoctoral Research Associate with expertise in protein-based mass spectrometry and /or proteomics.

Product Manager - Techne, Stone, Staffordshire
Bibby Scientific
Bibby Scientific Ltd is one of the world’s leading manufacturers of Laboratory bench-top scientific equipment. For more information about the company, please visit their website (www.bibby-scientific.com).


Assistant/Associate Professors
Chinese University of Hong Kong
The newly established School of Biomedical Sciences, Stem Cell and Regeneration theme is actively looking for stem cell biologist over the next 2 years.

Macromolecular X-ray Crystallgrapher
Xtal Biostructures
Ph.D. Protein Crystallographer: We seek an experienced crystallographer with post-doctoral experience to participate in a number of our diverse structural biology activities.

Marketing Communications Specialist Position in San Jose, CA
Thermo Fisher Scientific
This position, based in San Jose, CA within the SID Division, will manage promotion of Thermo Scientific mass spectrometry products and services.


St. Jude Children's Research Hospital has an opening for a Senior Research Technologist (Job Number 18046)
St Judes Research Hospital
St. Jude Children's Research Hospital, located in Memphis, Tennessee, is a premier center for research and treatment of potentially fatal childhood diseases, including cancer and certain blood, genetic, and immunodeficiency disorders. The hospital's mission is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment.

A simple, fast and quantitative single-step dead-cell indicator for flow cytometry
life technologies

We have evaluated a series of new compounds for dead cell stain and identified a new product, SYTOX® AADvancedTM dead cell stain, which demonstrates improved properties over 7-AAD. These properties make the SYTOX® AADvancedTM dead cell stain a simple, fast and quantitative single-step no-wash dead-cell indicator as well as ideal for use in multicolor application requiring DNA content.

Protein array-based screening of autoantibody signatures
Fondazione Istituto Nazionale Genetica Molecolare

The evidence for an association between autoimmune diseases and chronic HCV infection has been clearly established. To this aim, a protein array was employed to analyze serum samples of HCV patients w/wo autoimmune complications, of patients with autoimmune hepatitis but not infected with HCV and of healthy donors as controls. A panel of autoantigens able to discriminate among the three groups of patients was identified for potential use as biomarkers.
  


Microwave Assisted Synthesis of Potentially Bioactive Molecules

John Spencer, Reader in Organic Chemistry, Greenwich University, speaking at Screening, MedChem and ADMET Europe 2009

Detection of Angiogenic Growth Factor by Microcantilever Biosensors

Riccardo Castagna, PhD Student, Politecnico di Torino, speaking at Molecular Diagnostics Europe 2009

Multiplexed Diagnostics 2009 Market Report
Published March 2009

Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized.

Cancer Personalized Medicine 2008
Published July 2008

The Cancer Personalized Medicine marketplace represents the paradigm for personalized medicine market evolution and Select Biosciences focuses in this report on the various commercialized cancer predictor tests, their current status, traction in the marketplace, quantitative market opportunities, and the factors that are driving as well as challenging the expansion of this space. Personalized Medicine, especially as it relates to Cancer, is undergoing significant growth and this report focuses i